PVLA
Palvella Therapeutics
PVLA
PVLA
90 hedge funds and large institutions have $179M invested in Palvella Therapeutics in 2017 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 27 increasing their positions, 16 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.02% more ownership
Funds ownership: 0.64% → 0.66% (+0.02%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
83% less call options, than puts
Call options by funds: $27K | Put options by funds: $156K
Holders
90
Holding in Top 10
1
Calls
$27K
Puts
$156K
Top Buyers
| 1 | +$3.37M | |
| 2 | +$2.21M | |
| 3 | +$1.94M | |
| 4 |
Renaissance Technologies
New York
|
+$1.91M |
| 5 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
+$1.59M |
Top Sellers
| 1 | -$6.61M | |
| 2 | -$2.74M | |
| 3 | -$2.27M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.51M |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$452K |